Geared to an inter-professional community of clinicians, researchers, and trainees, the series is intended to provoke discussion and community building. The Talks, are intended to provide an overview of the health innovation landscape while introducing the ‘tools and competencies’ needed to systematically ‘translate’ science more effectively.
As part of the graduate seminar, MSC 1000: Fundamentals of Translational Research, the discussion series is hosted by Faculty of Medicine’s Translational Research Program (TRP) and the five collaborating Departments participating in the development of the Toronto Translational HUB (Department of Psychiatry, Medicine, Imaging, Surgery and Paediatrics).
Each seminar in the series is two hours. During the first hour, TRP first-year students will facilitate a discussion among all the panel discussants and audience about Translational challenges and opportunities. During the second hour, each of the discussants will meet in smaller groups with attendees to continue the conversation and network.
Join our TR Talk mailing list here.
Challenges and Promises in Clinical Trials for Orphan Populations
Successful progression through clinical trials requires not only the generation of evidence but also the ability to navigate regulations and associated administrative requirements. This week TR talk brings together a panel of experts to share their experiences from the front lines of clinical trials. Their failures, successes, and everything they learned along the way.
Ms. Pat Furlong, Founding President and CEO, Parent Project Muscular Dystrophy (PPMD)
Dr. Daniel Morgenstern, Director, New Agent and Innovative Therapy Program (NAIT); Hematology/Oncology at SickKids
Dr. Richard Sugarman, Chair, Ontario Cancer Research Ethics Board
Dr. Mark Kieran, Clinical Trial Lead, Pediatrics Program, Oncology Clinical Development, Bristol-Myers Squibb
Regulatory Jurisdictions in Medical Devices
Widgets, gadgets, doodads, and whatsits. The term healthcare innovation is often descriptive of a device or technology. Understanding regulatory requirements specific to devices is crucial to improving health. Join TR talks this week to learn from device experts who can show you which roads to take, and which to avoid.
Dr. Brian Courtney, Clinical Scientist, Sunnybrook and Executive Chairman, Conavi Medical
Dr. Bradley Strauss, Chief, Schulich Heart Program and Head, Cardiology, Sunnybrook Health Sciences Centre.
Mr. Lahav Gil, CEO, Relay Medical Corp.
Research has, historically, been a core focus of Universities. However, the production of knowledge and its application outside academe are not synonymous. In publicly funded institutions, especially, do researchers have a social imperative to share the knowledge produced with the broader society? Is mobilizing or communicating knowledge for broader social, economic or political benefit an obligation of (publicly funded) institutions? Let’s discuss the relationship between research, translation and innovation.
Prof. Vivek Goel, Vice-President, Research and Innovation, University of Toronto
Prof. Melanie Barwick, Psychologist and Health Systems Research Scientist, Child and Youth Mental Health Research Unit, SickKids
Translating knowledge into new or better ways of doing things does not mean that they will be used. Innovations that are not used, defused or scaled, that don’t produce change or impact, are they still innovations? What are the challenges and opportunities in implementing new ideas? How do we implement and manage change?
Prof. Norman Rosenblum, Scientific Director, CIHR Institute of Nutrition, Metabolism and Diabetes
Julia Hanigsberg, President and CEO, Holland Bloorview Kids Rehabilitation Hospital
Dr. Gary Levy, Professor of Immunology and Surgery, University of Toronto
Frontiers in Translation
The future is now. How do we look at the present and the future of innovation? What are the opportunities, challenges and obligations for improving the future of health, medicine and care in Ontario, Canada and the world?
Dr. Ulrich Krull, Vice-President and Principal, University of Toronto Mississauga
Dr. Gary Lewis, Director of the U of T Banting and Best Diabetes Centre and Scientific Lead for the SPOR Network in Diabetes and its Related Complications